Literature DB >> 29420040

Integrity of Glycosylation Processing of a Glycan-Depleted Trimeric HIV-1 Immunogen Targeting Key B-Cell Lineages.

Anna-Janina Behrens1, Abhinav Kumar1, Max Medina-Ramirez2, Albert Cupo3, Kevin Marshall3, Victor M Cruz Portillo3, David J Harvey1, Gabriel Ozorowski4, Nicole Zitzmann1, Ian A Wilson4,5, Andrew B Ward4, Weston B Struwe1, John P Moore3, Rogier W Sanders2,3, Max Crispin1,6.   

Abstract

Broadly neutralizing antibodies (bNAbs) that target the trimeric HIV-1 envelope glycoprotein spike (Env) are tools that can guide the design of recombinant Env proteins intended to engage the predicted human germline precursors of bNAbs (gl-bNAbs). The protein components of gl-bNAb epitopes are often masked by glycans, while mature bNAbs can evolve to accommodate or bypass these shielding glycans. The design of germline-targeting Env immunogens therefore includes the targeted deletion of specific glycan sites. However, the processing of glycans on Env trimers can be influenced by the density with which they are packed together, a highly relevant point given the essential contributions under-processed glycans make to multiple bNAb epitopes. We sought to determine the impact of the removal of 15 potential N-glycan sites (5 per protomer) from the germline-targeting soluble trimer, BG505 SOSIP.v4.1-GT1, using quantitative, site-specific N-glycan mass spectrometry analysis. We find that, compared with SOSIP.664, there was little overall change in the glycan profile but only subtle increases in the extent of processing at sites immediately adjacent to where glycans had been deleted. We conclude that multiple glycans can be deleted from BG505 SOSIP trimers without perturbing the overall integrity of the glycan shield.

Entities:  

Keywords:  Env; HIV-1 vaccine design; envelope; glycoproteomics; glycosylation; immunogen design; mass spectrometry; virus

Mesh:

Substances:

Year:  2018        PMID: 29420040      PMCID: PMC5846105          DOI: 10.1021/acs.jproteome.7b00639

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  94 in total

Review 1.  Optimal and consistent protein glycosylation in mammalian cell culture.

Authors:  Patrick Hossler; Sarwat F Khattak; Zheng Jian Li
Journal:  Glycobiology       Date:  2009-06-03       Impact factor: 4.313

2.  Fragmentation of negative ions from carbohydrates: part 1. Use of nitrate and other anionic adducts for the production of negative ion electrospray spectra from N-linked carbohydrates.

Authors:  David J Harvey
Journal:  J Am Soc Mass Spectrom       Date:  2005-05       Impact factor: 3.109

3.  Antibody neutralization and escape by HIV-1.

Authors:  Xiping Wei; Julie M Decker; Shuyi Wang; Huxiong Hui; John C Kappes; Xiaoyun Wu; Jesus F Salazar-Gonzalez; Maria G Salazar; J Michael Kilby; Michael S Saag; Natalia L Komarova; Martin A Nowak; Beatrice H Hahn; Peter D Kwong; George M Shaw
Journal:  Nature       Date:  2003-03-20       Impact factor: 49.962

4.  Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16.

Authors:  Marie Pancera; Syed Shahzad-Ul-Hussan; Nicole A Doria-Rose; Jason S McLellan; Robert T Bailer; Kaifan Dai; Sandra Loesgen; Mark K Louder; Ryan P Staupe; Yongping Yang; Baoshan Zhang; Robert Parks; Joshua Eudailey; Krissey E Lloyd; Julie Blinn; S Munir Alam; Barton F Haynes; Mohammed N Amin; Lai-Xi Wang; Dennis R Burton; Wayne C Koff; Gary J Nabel; John R Mascola; Carole A Bewley; Peter D Kwong
Journal:  Nat Struct Mol Biol       Date:  2013-05-26       Impact factor: 15.369

5.  The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.

Authors:  Christopher N Scanlan; Ralph Pantophlet; Mark R Wormald; Erica Ollmann Saphire; Robyn Stanfield; Ian A Wilson; Hermann Katinger; Raymond A Dwek; Pauline M Rudd; Dennis R Burton
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

6.  Microsecond Dynamics and Network Analysis of the HIV-1 SOSIP Env Trimer Reveal Collective Behavior and Conserved Microdomains of the Glycan Shield.

Authors:  Thomas Lemmin; Cinque Soto; Jonathan Stuckey; Peter D Kwong
Journal:  Structure       Date:  2017-09-07       Impact factor: 5.006

7.  Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies.

Authors:  Laura K Pritchard; Daniel I R Spencer; Louise Royle; Camille Bonomelli; Gemma E Seabright; Anna-Janina Behrens; Daniel W Kulp; Sergey Menis; Stefanie A Krumm; D Cameron Dunlop; Daniel J Crispin; Thomas A Bowden; Christopher N Scanlan; Andrew B Ward; William R Schief; Katie J Doores; Max Crispin
Journal:  Nat Commun       Date:  2015-06-24       Impact factor: 14.919

8.  Stable 293 T and CHO cell lines expressing cleaved, stable HIV-1 envelope glycoprotein trimers for structural and vaccine studies.

Authors:  Nancy P Y Chung; Katie Matthews; Helen J Kim; Thomas J Ketas; Michael Golabek; Kevin de Los Reyes; Jacob Korzun; Anila Yasmeen; Rogier W Sanders; Per Johan Klasse; Ian A Wilson; Andrew B Ward; Andre J Marozsan; John P Moore; Albert Cupo
Journal:  Retrovirology       Date:  2014-04-25       Impact factor: 4.602

9.  Cell- and Protein-Directed Glycosylation of Native Cleaved HIV-1 Envelope.

Authors:  Laura K Pritchard; David J Harvey; Camille Bonomelli; Max Crispin; Katie J Doores
Journal:  J Virol       Date:  2015-06-17       Impact factor: 5.103

10.  A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.

Authors:  Rogier W Sanders; Ronald Derking; Albert Cupo; Jean-Philippe Julien; Anila Yasmeen; Natalia de Val; Helen J Kim; Claudia Blattner; Alba Torrents de la Peña; Jacob Korzun; Michael Golabek; Kevin de Los Reyes; Thomas J Ketas; Marit J van Gils; C Richter King; Ian A Wilson; Andrew B Ward; P J Klasse; John P Moore
Journal:  PLoS Pathog       Date:  2013-09-19       Impact factor: 6.823

View more
  15 in total

Review 1.  Glycomics and glycoproteomics of viruses: Mass spectrometry applications and insights toward structure-function relationships.

Authors:  John F Cipollo; Lisa M Parsons
Journal:  Mass Spectrom Rev       Date:  2020-04-29       Impact factor: 10.946

2.  Overcoming Challenges in Structural Characterization of HIV-1 Envelope Glycoprotein by LC-MS/MS.

Authors:  Vera B Ivleva; Jonathan W Cooper; Frank J Arnold; Q Paula Lei
Journal:  J Am Soc Mass Spectrom       Date:  2019-05-20       Impact factor: 3.109

Review 3.  Mass spectrometry for the identification and analysis of highly complex glycosylation of therapeutic or pathogenic proteins.

Authors:  Yukako Ohyama; Kazuki Nakajima; Matthew B Renfrow; Jan Novak; Kazuo Takahashi
Journal:  Expert Rev Proteomics       Date:  2020-05-28       Impact factor: 3.940

Review 4.  Harnessing post-translational modifications for next-generation HIV immunogens.

Authors:  Joel D Allen; Rogier W Sanders; Katie J Doores; Max Crispin
Journal:  Biochem Soc Trans       Date:  2018-05-21       Impact factor: 5.407

5.  Closing and Opening Holes in the Glycan Shield of HIV-1 Envelope Glycoprotein SOSIP Trimers Can Redirect the Neutralizing Antibody Response to the Newly Unmasked Epitopes.

Authors:  Rajesh P Ringe; Pavel Pugach; Christopher A Cottrell; Celia C LaBranche; Gemma E Seabright; Thomas J Ketas; Gabriel Ozorowski; Sonu Kumar; Anna Schorcht; Marit J van Gils; Max Crispin; David C Montefiori; Ian A Wilson; Andrew B Ward; Rogier W Sanders; P J Klasse; John P Moore
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

6.  Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core.

Authors:  Andrew J Borst; Connor E Weidle; Matthew D Gray; Brandon Frenz; Joost Snijder; M Gordon Joyce; Ivelin S Georgiev; Guillaume Be Stewart-Jones; Peter D Kwong; Andrew T McGuire; Frank DiMaio; Leonidas Stamatatos; Marie Pancera; David Veesler
Journal:  Elife       Date:  2018-11-07       Impact factor: 8.140

Review 7.  Protein and Glycan Mimicry in HIV Vaccine Design.

Authors:  Gemma E Seabright; Katie J Doores; Dennis R Burton; Max Crispin
Journal:  J Mol Biol       Date:  2019-04-24       Impact factor: 5.469

8.  AIDS Vaccine Research Subcommittee (AVRS) Consultation: Early-Life Immunization Strategies against HIV Acquisition.

Authors:  Anjali Singh; Sallie Permar; Tobias R Kollmann; Ofer Levy; Mary Marovich; Kristina De Paris
Journal:  mSphere       Date:  2019-07-17       Impact factor: 4.389

9.  Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques.

Authors:  Norbert Pardi; Celia C LaBranche; Guido Ferrari; Derek W Cain; István Tombácz; Robert J Parks; Hiromi Muramatsu; Barbara L Mui; Ying K Tam; Katalin Karikó; Patricia Polacino; Christopher J Barbosa; Thomas D Madden; Michael J Hope; Barton F Haynes; David C Montefiori; Shiu-Lok Hu; Drew Weissman
Journal:  Mol Ther Nucleic Acids       Date:  2019-03-21       Impact factor: 10.183

10.  Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability.

Authors:  Viktoriya Dubrovskaya; Karen Tran; Gabriel Ozorowski; Javier Guenaga; Richard Wilson; Shridhar Bale; Christopher A Cottrell; Hannah L Turner; Gemma Seabright; Sijy O'Dell; Jonathan L Torres; Lifei Yang; Yu Feng; Daniel P Leaman; Néstor Vázquez Bernat; Tyler Liban; Mark Louder; Krisha McKee; Robert T Bailer; Arlette Movsesyan; Nicole A Doria-Rose; Marie Pancera; Gunilla B Karlsson Hedestam; Michael B Zwick; Max Crispin; John R Mascola; Andrew B Ward; Richard T Wyatt
Journal:  Immunity       Date:  2019-11-12       Impact factor: 43.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.